SEMAGLUTIDE FOR WEIGHT LOSS

CHARLOTTE NC | MATTHEWS NC

(704) 243-7106

Weight Loss Made Easier

Semaglutide is a new weight loss method that uses weekly injections to target and regulate appetite and food intake.

SEMAGLUTIDE FOR WEIGHT LOSS

CHARLOTTE NC | MATTHEWS NC

(704) 243-7106

Weight Loss Made Easier

Semaglutide is a new weight loss method that uses weekly injections to target and regulate appetite and food intake.

More About Semaglutide for Weight Loss

Semaglutide for weight loss is a non-stimulant (safe for patients with heart disease), non-addictive weekly injection that helps to reduce appetite and food cravings while increasing feelings of fullness. Semaglutide has been proven to lower weight, waist size, blood pressure, blood sugar, and inflammation.

FAQs about Semaglutide

  • Drug approval research trials showed a majority of patients had at least 15% weight loss, with many losing more than 20%!

Semaglutide helps with weight loss by mimicking the GLP-1 hormone. It:

  • Stimulates insulin secretion
  • Delays gastric emptying
  • Decreases glucagon levels
  • Reduces appetite

  • Semaglutide has been safely used for the treatment of obesity since 2021 and for diabetes since 2017.
  • Medication Disclosures: At Learn2Lose, these injectable medications are obtained from 503A and 503B compounding pharmacies. 503A compounding pharmacies are licensed by their State Board of Pharmacy. 503B outsourcing facilities are regulated and inspected by the FDA. Compounding pharmacies and outsourcing facilities are currently able to produce these medications due to supply shortages as listed on the FDA Drug Shortage website. Compounded versions of medications are not evaluated by the FDA nor do they receive FDA approval, even if the branded parent compound is FDA approved. Our programs are NOT affiliated with Novo Nordisk or  Eli Lily and Company.

Semaglutide is not for you if you have:

  • Diabetic retinopathy
  • Low blood sugar
  • Kidney issues
  • Pancreatitis
  • Medullary thyroid cancer (or family history)
  • Multiple endocrine neoplasia type 2

Medication Disclosures: At Learn2Lose, these injectable medications are obtained from 503A and 503B compounding pharmacies. 503A compounding pharmacies are licensed by their State Board of Pharmacy. 503B outsourcing facilities are regulated and inspected by the FDA. Compounding pharmacies and outsourcing facilities are currently able to produce these medications due to supply shortages as listed on the FDA Drug Shortage website. Compounded versions of medications are not evaluated by the FDA nor do they receive FDA approval, even if the branded parent compound is FDA approved. Our programs are NOT affiliated with Novo Nordisk or  Eli Lily and Company.

More About Semaglutide for Weight Loss

Semaglutide is a non-stimulant (safe for patients with heart disease), non-addictive weekly painless injection into belly fat with a tiny needle to reduces appetite and food cravings while increasing feeling of fullness. Semaglutide helps lower weight, waist size, blood pressure, blood sugar, and inflammation.

FAQs about Semaglutide

  • Majority of patients had at least 15% weight loss, with many losing more than 20%!

  • Semaglutide for weight loss works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake; it is a powerful appetite suppressant.

  • Semaglutide has been safely used for the treatment of obesity since 2021 and for diabetes since 2017.
  • Medication Disclosures: At Learn2Lose, these injectable medications are obtained from 503A and 503B compounding pharmacies. 503A compounding pharmacies are licensed by their State Board of Pharmacy. 503B outsourcing facilities are regulated and inspected by the FDA. Compounding pharmacies and outsourcing facilities are currently able to produce these medications due to supply shortages as listed on the FDA Drug Shortage website. Compounded versions of medications are not evaluated by the FDA nor do they receive FDA approval, even if the branded parent compound is FDA approved. Our programs are NOT affiliated with Novo Nordisk or  Eli Lily and Company.

Semaglutide is not for you if you have:

  • Diabetic retinopathy
  • Low blood sugar
  • Kidney issues
  • Pancreatitis
  • Medullary thyroid cancer (or family history)
  • Multiple endocrine neoplasia type 2